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Aims: To determine the frequency of viral pathogens causing upper respiratory tract infec-
tions in non-hospitalized, symptomatic adults in the city of Rio de Janeiro.
Methods:  Respiratory samples (nasal/throat swabs) were collected between August 2010 and
November 2012 and real time PCR was used to detect different viral pathogens.
Results:  Viruses were detected in 32.1% (43/134) of samples from 101 patients. Speciﬁcally,
9%  (12/134) were positive for HBoV, 8.2% (11/134) were positive for HAdV, 5.2% (7/134) were
positive  for HRV, and 1.5% (2/134) were positive for FLUBV or HMPV, as single infections.
HRSV-A,  HPIV-3, and HCoV-HKU1 were detected in one (0.75%) sample each. Co-infections
were  detected in 4.8% (6/134) of the samples. Peaks of viral infections were observed in
March,  April, May, August, and October. However, positive samples were  detected all year
round.  Only 23.3% (10/43) of the positive samples were collected from patients with febrile
illness.
Conclusion:  Results presented in this report suggest that respiratory viral infections are
largely  under diagnosed in immunocompetent adults. Although the majority of young adultinfections  are not life-threatening they may impose a signiﬁcant burden, especially in devel-
oping  countries since these individuals represent a large fraction of the working force.
© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroductionAcute respiratory infections represent a signiﬁcant mor-
bidity  and mortality burden worldwide and are caused
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infections a global health concern. Since 1977, the World
Health  Organization has advocated the surveillance of acute
viral  respiratory disease programs  worldwide.4 However, the
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ajority of the data collected regarding infections in chil-
ren  and the epidemiology of community-acquired viral
espiratory infections among adults is insufﬁcient, perhaps
ith  the exception of infections caused by the inﬂuenza
irus. Most data available focuses on speciﬁc populations
uch as immunosuppressed,5–9 homeless,10,11 or elderly
ndividuals.5,12,13
Viruses are the leading causes of acute respiratory disease
hroughout the world. Causative agents of respiratory disease
n  humans include human respiratory syncytial virus (HRSV),
uman  parainﬂuenza virus (HPIV), inﬂuenza A virus (FLUAV)
nd  inﬂuenza B virus (FLUBV), human adenovirus (HAdV),
uman  coronavirus (HCoV), human rhinovirus (HRV), human
etapneumovirus (HMPV), and human bocavirus (HBoV).1–3
n addition, two human polyomaviruses (HPyV), KIPyV and
UPyV,  have been detected in patients with respiratory
nfections.1,2
In 2000, the Brazilian Ministry of Health established a coun-
rywide  surveillance system for respiratory viral infections.
his  system comprises a network of sentinel units that include
utpatient  clinics, emergency care departments, and general
ospitals  that issue a weekly report (using an online system)
nforming the total number of visits and the number of visits
ssociated  with inﬂuenza-like illness (ILI) (deﬁned as a case
f  fever accompanied by cough or sore throat with no other
iagnosis).14,15 The system is designed to detect only a small
umber of virus species including FLUAV, FLUBV, HRSV, HAdV,
nd  HPIV-1, -2, and -3.14 Infections caused by other important
iral  pathogens such as HPMV, HRV, HBoV, and HCoV are not
onitored.
The  aim of this study was  to determine the frequency and
ype  of upper respiratory viral infections in non-hospitalized
dults in the city of Rio de Janeiro, Brazil over a period of two
ears  using molecular diagnostic methods.
atients  and  methods
mmunocompetent patients (n = 134) who attended the
mmunology Service of the Hospital Universitário Clementino
raga  Filho (HUCFF)/Federal University of Rio de Janeiro (UFRJ)
etween  August 2010 and November 2012 (median age 50.5
ears;  ranging from 19 to 80 years) were  enrolled in the present
tudy.  The age distribution of the subjects was as follows: six
ere  19–24 years old, 21 were 25–35 years old, 17 were 36–45
ears  old, 33 were  46–55 years old, 37 were 56–65 years old, and
0  were  >65 years old (Table 1).
Respiratory samples (nasal/throat swabs) were  obtained
rom  all participants. Following collection swabs were placed
nto  viral transport media and stored at −70 ◦C until processed.
elevant clinical information including age, sex, and clini-
al  symptoms were  collected during the medical visit using
 standardized questionnaire. Respiratory illness was deﬁned
y  the presence of rhinorrhea and/or cough and/or respiratory
istress  and/or sore throat, with or without fever.
Nucleic acid was  extracted from 200 L of the collected
amples using the Wizard Genomic DNA Puriﬁcation KIT
Promega,  Madison, WI)  and the Totally RNA® Kit (Applied
iosystems/Ambion, Grand Island, NY) according to the
anufacturer’s instructions. Specimens were tested for the 1 5;1  9(1):30–35  31
presence of FLUAV and FLUBV,16 HRSV (variant A and B),17
HPIV species 1–4,18 HRV species A and B (HRV-A/B),19 HMPV,20
HAdV,21 HBoV species 1–4,22,23 WUPyV and KIPyV,24 and HCoV
species OC43, 229E, NL63, and HKU125 by real time PCR assays.
Genomic  RNAs of FLUV, HRSV, HPIV, HRV, HMPV and HCoV
were  subjected to one cycle of reverse transcription (5 min
at  25 ◦C followed by 45 min  at 42 ◦C) using 50 pmol random
primer (hexamer pd[N]6, Life Technologies, Carlsbad, CA, USA)
in  a Veriti 96 well (Applied Biosystems, Foster City, CA, USA)
thermocycler, prior to PCR ampliﬁcation. Real-time PCR ampli-
ﬁcations  were performed for each virus separately, in an ABI
StepOne  Real-time PCR System (Applied Biosystems). The
ampliﬁcation conditions consisted of 10 min  at 95 ◦C, followed
by  45 cycles of 10 s at 95 ◦C and 60 s at 60 ◦C. Ampliﬁcation
was carried out in 24 L reaction volumes, including 5 L of
DNA,  speciﬁc primer for each virus and 12 L of Maxima® SYBR
Green  qPCR Master Mix (Fermentas/Thermo Fischer Scientiﬁc,
Canada).  Each PCR assay for HMPV, HRV-A/B, HAdV, KIPyV or
WUPyV used a single pair of primers. Multiplex assays were
used  to detect and discriminate the distinct species of FLUV,
HRSV,  HBoV, HIPV and HCoV.
A conventional RT-PCR protocol was  used for detection of
HRV  species C (HRV-C).26 After the reverse transcription step,
the  viral cDNA was subjected to one step of 8 min  at 94 ◦C
followed  by 35 cycles of PCR each consisting of 45 s at 94 ◦C,
45  s at 60 ◦C and 45 s at 72 ◦C, and a ﬁnal extension step of
8  min  at 72 ◦C in a Veriti 96 well thermocycler. The PCR prod-
ucts  were  analyzed by 1.2% (w/v) agarose gel electrophoresis
and visualized by staining with ethidium bromide.
Positive and negative controls were  included in each run.
Infected  cell cultures were  used as positive controls for HRSV
(HEp-2  cells), HPIV (Vero cells), HMPV (LLC-MK2 cells), HRV
(MRC-5  cells) and HAdV (A549 cells). Positive controls of
FLUAV  and FLUBV consisted of allantoic ﬂuid from FLUV
infected embryonic eggs. Clinical samples of HRV-C, HCoV,
KIPyV,  WUPyV and HBoV, conﬁrmed by PCR ampliﬁcation and
sequencing  analysis, were  obtained from patients with respi-
ratory  illness and used as positive controls. Negative controls
consisted  of viral transport medium.
Results
Patients (n = 101) (16 male and 85 female) presenting with
respiratory illness symptoms were enrolled in the present
study.  Respiratory samples (n = 134) were collected and ana-
lyzed  for the presence of viruses. The most common
symptoms observed were cough (88.4%), sneezing (67.4%), and
nasal  congestion (58.1%). Fever was reported in 22.4% (30/134)
of  respiratory infection episodes (Fig. 1).
Patients were  stratiﬁed into six age groups (Table 1). The
overall  detection frequency of any viral respiratory infections
was  33.3% (2/6) in individuals <24 years old, 33.3% (7/21) among
those  25–35 years old, 41.2 (7/17) among patients 36–45 years
old,  24.2 (8/33) among patients 46–55 years old, 35.1 (13/37)
among  patients 56–65 years old, and 30.0% among patients >65
(6/20) years old. The identiﬁcation rates of respiratory viruses
did  not differ signiﬁcantly between age groups.
Co-infections occurred in six (4.5%) specimens, of which
ﬁve  were double infections (HAdV + HBoV1; HAdV + HBoV2;
32
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Table 1 – Age distribution of patients presenting with respiratory virus infections.
Age group (years) Number of subjects Number of positive samples
HAdV HBoV-1 HBoV-2 HRV-A/B HRV-C FLUBV HMPV HRSV-A HCoV-HKU1 HPIV-3 Co-infections Total (%)
<24 6 1 1 2 (33.3)
25–35 21 1 1 3 1 1 7 (33.3)
36–45 17 2 1 1 1 1 1 7 (41.2)
46–55 33 1 1 1 1 1 3 (HAdV + HBoV-1;
HAdV + HBoV-2,
HAdV + KIPyV + HRV-
A/B)
8 (24.2)
56–65 37 3 4 1 1 1 3
(HAdV + HCoV-229E;
HBoV-2 + HRV-A/B;
HBoV-2 + KIPyV)
13 (35.1)
>65 20 3 1 1 1 6 (30.0)
Total 134 11 4 8 4 3 2 2 1 1 1 6 43 (32.1)
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Fig. 1 – Frequency of respiratory symptoms in patients with
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riple infection (HAdV + HRV-A/B + KIPyV). Co-infections were
nly  detected among patients over 45 years of age and symp-
oms  were  not different from single infected individuals.
Forty-three samples (32.1%) collected from 40 patients were
ositive  for at least one of the viral pathogens screened for,
amely  11 HAdV, 12 HBoV (four HBoV-1 and eight HBoV-2),
even  HRV (4HRV-A/B and three HRV-C), two HMPV posi-
ive,  two FLUVB positive, and one HRSV-A, HCoV (HKU1), and
PIV-3.  Co-infections with these viruses were  observed in six
amples including one sample positive for KIPyV. FLUVA, HPIV-
, 2 and 4, HBoV-3 and 4, and WUPyV were  not detected in
ny  of the samples examined (Table 1). Only 23.3% (10/43) of
he  virus-positive samples were collected from patients with
ebrile  illness.
Of  the seven (5.52%, n = 134) patients presenting only with
RV  (four positive for HRV-A/B and three for HRV-C) the
ost  pronounced symptoms were  cough (100%), sneezing
71.4%),  nasal congestion (57.1%), watery eyes (57.1%), rhinor-
hea  (42.9%), and fever (42.9%) (Fig. 2). Symptoms were similar
or  infections caused by HRV-A/B or HRV-C.HAdV was  detected in samples from 11 (8.2%) patients
resenting with a single infection and in samples from four
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ig. 2 – Frequency of symptoms associated with HAdV,
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KIPyV + HRV-A/B. The most frequent symptoms presented by
patients infected with HAdV were cough (91%), sneezing (82%),
nasal  congestion (54.4%), and myalgia (36.4%) (Fig. 2).
Of  the 16 (11.9%) patients infected with HBoV (consider-
ing both single and co-infections), ﬁve patients were infected
with  HBoV-1 (four single infections and one co-infection with
HAdV)  and 11 were infected with HBoV-2. Eight patients had
single  infections and three were  co-infected with HRV-A/B,
KIPyV,  and HAdV. The most common symptoms observed
among HBoV single-infected patients were cough (66.7%),
sneezing (50%), nasal congestion (50%), and rhinorrhea (33.3%)
(Fig.  2). Clinical symptoms were  similar for HBoV-1 and HBoV-2
infections.
FLUVB  was  detected in two (1.5%) patients. A 45-year old
female  presenting with cough and myalgia and a 48-year old
female  presenting with cough, sneezing, watering eyes, nasal
congestion,  and sore throat.
Two  (1.5%) HMPV infections were detected. The ﬁrst case
was  a 69-year old female with cough, sneezing, nasal conges-
tion,  and myalgia, and the second was  a 25-year old female
with  cough, rhinorrhea, nasal congestion, and sore throat.
HCoV-HKU1 was  detected as a single infection in a 63
year-old male presenting with cough and nasal congestion.
Co-infection with HCoV-229E and HAdV was  detected in a 57-
year  old female with cough, sore throat, rhinorrhea, sneezing,
nasal  congestion, and myalgia.
A 31-year old male presenting with fever, cough, and sore
throat  was infected with HRSV-A and a 45-year old female
patient  infected with HPIV-3 presented with cough, rhinor-
rhea,  sneezing, nasal congestion, and a sore throat. KIPyV was
only  detected in co-infections (Table 1).
Peaks of viral infections were observed primarily during
March (33.3%; n = 6), April (58.8% positivity; n = 17), May  (33.3%;
n  = 9), August (30.6% positivity; n = 49), and October (41.2% pos-
itivity;  n = 17). However, viruses were detected in samples all
year  round. There was  no sample collection during the months
of  January and December and only one sample was  collected
during  November (Fig. 3).
Discussion
The frequency of respiratory viral infections (RVIs) in immuno-
competent  adults is often overlooked; however, available data
suggest  that RVIs are responsible for a signiﬁcant number of
respiratory  infections affecting not only the elderly (persons
aged  ≥65 years) but also young adults.12,13,27–32 Although the
majority of infections in young adults are not life-threatening
they can impose a signiﬁcant burden on communities since
the  affected population represents a large fraction of the work
force  in developing countries. Data presented in this report
indicate  that 65.1% (28/43) of virus-positive samples were
detected  in patients <60 years of age.
In Brazil, most of the available data on adult RVI is restricted
to  immunocompromised or elderly patients with little data
collected  on RVIs presenting in immunocompetent adults. It
has been previously demonstrated that HAdV infections were
detected  in 8–24.1%, HPIV-3 in 32%, HRSV in 20%, HBoV in 12%,
HMPV  in 12%, FLUAV in 4%, and FLUBV in 4% of transplant
patients.8,33 HRV and HMPV were detected in 28.6% and 2%,
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Fig. 3 – Monthly distribution of acute respiratory viral
infections among adults in Rio de Janeiro between August
r
adults.  N Engl J Med. 2005;352:1749–59.2010  and November 2012.
respectively, in elderly patients.29 Even so, a study performed
in  Porto Alegre (Southern Brazil) between November 2008 and
October  2010 reported that 22% of infections in immunocom-
petent adult patients (median age 50.6 years of age) admitted
to  emergence rooms with ILI or severe acute respiratory infec-
tion  (SARI) were  caused by respiratory viruses, mostly FLUAV
and  HRV-A/B. FLUVB, HAdV, HPIV, HRSV, HMPV, and HCoV
were  less frequently detected.34 In the present study, the over-
all  frequency of virus detection was  32.1%. The discrepancy
in  detection rates could be attributed to differences in the
methodologies used, for example, in the former study some
samples  were  tested using an indirect immunoﬂuorescence
assay (IFA) and other samples were  tested using conventional
PCR  assays compared to the use of both conventional and real
time PCR assays to detect virus isolates in the present study.
The  sentinel surveillance system in Brazil focuses on mon-
itoring  infections caused by FLUAV and FLUBV and other
respiratory viruses such as HAdV, HPIV, HRSV, and HRV-A/B.
Samples  are sent to and tested in public health laboratories in
each state by IFA and all positive, inconclusive, and 10% of neg-
ative  samples are forwarded to one of three national reference
laboratories where they are retested by PCR for respiratory
viruses.14,15 Between 2000 and 2010 the Brazilian surveillance
system recorded 3,291,946 cases of ILI. Of these cases, 37,120
(1%  of total ILI visits) had nasopharyngeal samples collected
and  tested for viral infections. A total of 16,962 (45.7%) tested
samples  were  from patients over 15 years of age with 2604
(15.4%)  positive for respiratory viruses. Overall FLUAV and
HPIV-3  were  the most common viruses detected. However, the
detection  rate of FLUAV declined from 41% to 18% during this
period.15 In our study, HAdV, HBoV, and HRV were the most
common  viruses detected. FLUBV was  detected in only 1.5%
(2/134)  of tested samples and FLUAV was  not detected.It  should be underscored that FLUV was not detected
among patients over 60 years of age. The inﬂuenza vaccine
in  Brazil is freely distributed for at risk individuals including 0 1 5;1  9(1):30–35
pregnant women of all gestational ages, women  up to 45 days
after  childbirth, children from six months up to two years
of  age, people over 60 years of age, persons with chronic
non-communicable diseases, native Indians, and healthcare
workers.14 According to the Ministry of Health, inﬂuenza vac-
cine  coverage in Brazil between 2010 and 2013 reached 80–88%
of  the target population and may  explain the decline of FLUV
detection  over the years and the low frequency of FLUV infec-
tions  found in our study. Lima et al.33 collected samples
between August 2011 and August 2012 and detected FLUAV
and  FLUBV in only 4% of the samples using real time PCR.
Acute  viral respiratory disease surveillance programs
around the world monitor cases of febrile ILI, therefore
patients presenting with respiratory symptoms but with-
out  fever are usually not included in surveys.15,28,35,36 In the
present study we  used a broader deﬁnition for respiratory ill-
ness that included patients with and without fever. Afebrile
patients  accounted for 76.3% of the virus-positive samples
identiﬁed, suggesting that respiratory virus infections are
largely  undiagnosed, particularly among immunocompetent
adults.
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